Şahin Kaan Baydemir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Şahin Kaan Baydemir has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Hande Nur Öncü
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
10 shared publications - Oğuz Kaan Köksal
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
10 shared publications - Candost Hanedan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
9 shared publications - Vakkas Korkmaz
Lokman Hekim Universitesi
8 shared publications - Neslihan Öztürk
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
7 shared publications - Gökçen Ege
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
6 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Substantial but not focal lymphovascular space invasion independently predicts lymph node metastasis in uterine-confined endometrial cancer: implications for the FIGO 2023 staging system
Ege G, et al. J Gynecol Oncol. 2027 ;38:e38. https://doi.org/10.3802/jgo.2027.38.e38
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessSubstantial but not focal lymphovascular space invasion independently predicts lymph node metastasis in uterine-confined endometrial cancer: implications for the FIGO 2023 staging system
Ege G, et al. J Gynecol Oncol. 2027 ;38:e38. https://doi.org/10.3802/jgo.2027.38.e38
- Open Access
- 18 July 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (7) , 430
Substantial LVSI Is Independently Associated with Para-Aortic Nodal Metastasis in Patients Undergoing Laparoscopic Surgical Staging for Endometrial Cancer
Lymphovascular space invasion (LVSI) is a well-established prognostic factor in endometrial cancer; however, its independent contribution to para-aortic nodal metastasis remains incompletely defined. Identifying factors associated with nodal dissemination is important for surgical staging and postoperative management. This retrospective, single-center cohort study included 121 patients with endometrial cancer who underwent laparoscopic pelvic and para-aortic lymphadenectomy. The cohort was predominantly obese (median BMI: 32 kg/m2). Clinicopathological variables were analyzed using univariable and multivariable logistic regression models to identify associations with lymph node metastasis and para-aortic lymph node metastasis. Lymph node metastasis was observed in 16.5% of patients, including para-aortic involvement in 9.9%. In univariable analysis, the LVSI category was significantly associated with lymph node metastasis (p = 0.002), with substantial LVSI being present in 50.0% of patients with nodal metastasis compared with 14.9% of those without. LVSI was categorized as negative, focal, or substantial. In multivariable logistic regression analyses using negative LVSI as the reference category, substantial LVSI remained independently associated with both overall nodal metastasis (OR 5.44, 95% CI 1.67–17.65, p = 0.005) and para-aortic nodal metastasis (OR 6.98, 95% CI 1.81–26.78, p = 0.005), whereas focal LVSI was not significantly associated with either outcome. These findings suggest that the extent of LVSI may be relevant to nodal metastasis, with substantial LVSI showing a stronger association than focal LVSI.
- 18 July 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (7) , 430
Open AccessSubstantial LVSI Is Independently Associated with Para-Aortic Nodal Metastasis in Patients Undergoing Laparoscopic Surgical Staging for Endometrial Cancer
Lymphovascular space invasion (LVSI) is a well-established prognostic factor in endometrial cancer; however, its independent contribution to para-aortic nodal metastasis remains incompletely defined. Identifying factors associated with nodal dissemination is important for surgical staging and postoperative management. This retrospective, single-center cohort study included 121 patients with endometrial cancer who underwent laparoscopic pelvic and para-aortic lymphadenectomy. The cohort was predominantly obese (median BMI: 32 kg/m2). Clinicopathological variables were analyzed using univariable and multivariable logistic regression models to identify associations with lymph node metastasis and para-aortic lymph node metastasis. Lymph node metastasis was observed in 16.5% of patients, including para-aortic involvement in 9.9%. In univariable analysis, the LVSI category was significantly associated with lymph node metastasis (p = 0.002), with substantial LVSI being present in 50.0% of patients with nodal metastasis compared with 14.9% of those without. LVSI was categorized as negative, focal, or substantial. In multivariable logistic regression analyses using negative LVSI as the reference category, substantial LVSI remained independently associated with both overall nodal metastasis (OR 5.44, 95% CI 1.67–17.65, p = 0.005) and para-aortic nodal metastasis (OR 6.98, 95% CI 1.81–26.78, p = 0.005), whereas focal LVSI was not significantly associated with either outcome. These findings suggest that the extent of LVSI may be relevant to nodal metastasis, with substantial LVSI showing a stronger association than focal LVSI.
- 12 July 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (7) , e70408
Prognostic Impact of WHO 2020 Lymphovascular Space Invasion Categories in Endometrial Cancer: Substantial LVSI as an Independent Risk Factor and the Behavior of LVSI ‐Positive, Node‐Negative Disease
Aim: To evaluate the prognostic significance of lymphovascular space invasion (LVSI), classified according to the 2020 World Health Organization (WHO) criteria, on disease‐free survival (DFS) and overall survival (OS) in endometrial cancer, and to characterize the prognosis of LVSI‐positive, lymph node‐negative disease. Methods: This retrospective single‐center cohort study included 568 patients with endometrial carcinoma who underwent primary surgical treatment with comprehensive surgical staging, including lymph node assessment, between January 2023 and December 2025. LVSI was classified as absent, focal, or substantial. Survival outcomes were estimated by the Kaplan–Meier method and compared by log‐rank test. Independent predictors of DFS and OS were identified by multivariable Cox proportional hazards regression. A four‐group analysis combining LVSI and lymph node status was also performed. Results: LVSI was absent in 413 patients (72.7%), focal in 39 (6.9%), and substantial in 116 (20.4%). Median follow‐up was 20.0 months. On multivariable analysis, substantial LVSI was an independent predictor of reduced DFS (HR 2.22, 95% CI: 1.14–4.32; p = 0.018) and OS (HR 3.48, 95% CI: 1.34–9.00; p = 0.010), whereas focal LVSI did not retain independent prognostic significance. LVSI‐positive/lymph node‐negative patients had significantly worse DFS than LVSI‐negative/lymph node‐negative patients ( p < 0.001) and did not differ significantly from LVSI‐negative/lymph node‐positive patients ( p = 0.065), suggesting recurrence outcomes approaching those of node‐positive disease. Conclusion: Substantial LVSI is an independent adverse prognostic factor in endometrial cancer. LVSI‐positive/lymph node‐negative patients demonstrated recurrence outcomes approaching those of lymph node‐positive disease; given the limited follow‐up, this finding is hypothesis‐generating and requires prospective validation before informing treatment escalation.
- 12 July 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (7) , e70408
Prognostic Impact of WHO 2020 Lymphovascular Space Invasion Categories in Endometrial Cancer: Substantial LVSI as an Independent Risk Factor and the Behavior of LVSI ‐Positive, Node‐Negative Disease
Aim: To evaluate the prognostic significance of lymphovascular space invasion (LVSI), classified according to the 2020 World Health Organization (WHO) criteria, on disease‐free survival (DFS) and overall survival (OS) in endometrial cancer, and to characterize the prognosis of LVSI‐positive, lymph node‐negative disease. Methods: This retrospective single‐center cohort study included 568 patients with endometrial carcinoma who underwent primary surgical treatment with comprehensive surgical staging, including lymph node assessment, between January 2023 and December 2025. LVSI was classified as absent, focal, or substantial. Survival outcomes were estimated by the Kaplan–Meier method and compared by log‐rank test. Independent predictors of DFS and OS were identified by multivariable Cox proportional hazards regression. A four‐group analysis combining LVSI and lymph node status was also performed. Results: LVSI was absent in 413 patients (72.7%), focal in 39 (6.9%), and substantial in 116 (20.4%). Median follow‐up was 20.0 months. On multivariable analysis, substantial LVSI was an independent predictor of reduced DFS (HR 2.22, 95% CI: 1.14–4.32; p = 0.018) and OS (HR 3.48, 95% CI: 1.34–9.00; p = 0.010), whereas focal LVSI did not retain independent prognostic significance. LVSI‐positive/lymph node‐negative patients had significantly worse DFS than LVSI‐negative/lymph node‐negative patients ( p < 0.001) and did not differ significantly from LVSI‐negative/lymph node‐positive patients ( p = 0.065), suggesting recurrence outcomes approaching those of node‐positive disease. Conclusion: Substantial LVSI is an independent adverse prognostic factor in endometrial cancer. LVSI‐positive/lymph node‐negative patients demonstrated recurrence outcomes approaching those of lymph node‐positive disease; given the limited follow‐up, this finding is hypothesis‐generating and requires prospective validation before informing treatment escalation.
- Open Access
- 21 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (10) , 1561
Predictive Value of the CALLY Index for Interventional Management in Vaginal Cuff Hematoma Following Hysterectomy
Background/Objectives: Vaginal cuff hematoma is a recognized complication following hysterectomy, with a subset of patients requiring invasive intervention. No reliable bedside biomarker currently exists to identify at admission patients likely to fail conservative management. This study aimed to evaluate the incidence and clinical characteristics of symptomatic vaginal cuff hematoma across all hysterectomy approaches, and to assess the predictive performance of the CALLY index (CRP-albumin-lymphocyte index), a composite marker of inflammatory burden, immune function, and nutritional status, alongside the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) for identifying patients requiring interventional management. Methods: This retrospective cohort study included 61 patients with symptomatic vaginal cuff hematoma following hysterectomy in a major tertiary referral center (November 2022–July 2025). Patients were divided into conservative (n = 38) and interventional (n = 23) management groups. The CALLY index was calculated as [Albumin (g/dL) × Lymphocyte (×109/L)] ÷ [CRP (mg/L) × 10−2]. Receiver operating characteristic (ROC) curve analysis with the DeLong method was used to compare predictive performance. Results: The overall incidence of symptomatic vaginal cuff hematoma was 1.9% (73/3852 hysterectomies), with the highest rate following vaginal hysterectomy (3.32%) and the lowest after robotic hysterectomy (0.74%). Interventional management was required in 37.7% of patients. The interventional group had significantly higher CRP (192 vs. 62 mg/L, p < 0.001), NLR (7.53 vs. 4.17, p < 0.001), and SII (2308 vs. 1207, p < 0.001), and significantly lower CALLY index values (2.00 vs. 9.80, p < 0.001). The CALLY index demonstrated the highest predictive performance (AUC = 0.863, 95% CI: 0.762–0.964), outperforming SII (AUC = 0.801), NLR (AUC = 0.789), and PLR (AUC = 0.654). At the optimal cutoff of ≤2.89, the CALLY index yielded a sensitivity of 65.2% and a specificity of 92.1%. Conclusions: The CALLY index is a simple, routinely available composite biomarker that may help identify patients at higher risk for interventional management in symptomatic vaginal cuff hematoma. Its incorporation into postoperative assessment may improve risk stratification and support timely clinical decision-making.
- 21 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (10) , 1561
Open AccessPredictive Value of the CALLY Index for Interventional Management in Vaginal Cuff Hematoma Following Hysterectomy
Background/Objectives: Vaginal cuff hematoma is a recognized complication following hysterectomy, with a subset of patients requiring invasive intervention. No reliable bedside biomarker currently exists to identify at admission patients likely to fail conservative management. This study aimed to evaluate the incidence and clinical characteristics of symptomatic vaginal cuff hematoma across all hysterectomy approaches, and to assess the predictive performance of the CALLY index (CRP-albumin-lymphocyte index), a composite marker of inflammatory burden, immune function, and nutritional status, alongside the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) for identifying patients requiring interventional management. Methods: This retrospective cohort study included 61 patients with symptomatic vaginal cuff hematoma following hysterectomy in a major tertiary referral center (November 2022–July 2025). Patients were divided into conservative (n = 38) and interventional (n = 23) management groups. The CALLY index was calculated as [Albumin (g/dL) × Lymphocyte (×109/L)] ÷ [CRP (mg/L) × 10−2]. Receiver operating characteristic (ROC) curve analysis with the DeLong method was used to compare predictive performance. Results: The overall incidence of symptomatic vaginal cuff hematoma was 1.9% (73/3852 hysterectomies), with the highest rate following vaginal hysterectomy (3.32%) and the lowest after robotic hysterectomy (0.74%). Interventional management was required in 37.7% of patients. The interventional group had significantly higher CRP (192 vs. 62 mg/L, p < 0.001), NLR (7.53 vs. 4.17, p < 0.001), and SII (2308 vs. 1207, p < 0.001), and significantly lower CALLY index values (2.00 vs. 9.80, p < 0.001). The CALLY index demonstrated the highest predictive performance (AUC = 0.863, 95% CI: 0.762–0.964), outperforming SII (AUC = 0.801), NLR (AUC = 0.789), and PLR (AUC = 0.654). At the optimal cutoff of ≤2.89, the CALLY index yielded a sensitivity of 65.2% and a specificity of 92.1%. Conclusions: The CALLY index is a simple, routinely available composite biomarker that may help identify patients at higher risk for interventional management in symptomatic vaginal cuff hematoma. Its incorporation into postoperative assessment may improve risk stratification and support timely clinical decision-making.
- 28 April 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (5) , e70290
The Association Between the Hemoglobin–Albumin–Lymphocyte–Platelet ( HALP ) Score and Lymph Node Metastasis in Early and Locally Advanced Cervical Cancer
Objective: To investigate the association between hemoglobin–albumin–lymphocyte–platelet (HALP) score and lymph node metastasis (LNM) in patients with early and locally advanced cervical cancer. Methods: This retrospective observational cohort study included patients with FIGO 2018 stage IA–IIIC cervical cancer treated at a tertiary gynecologic oncology center between November 2022 and January 2025. Lymph node status was determined by pathological and/or radiological evaluation. HALP score was calculated using pretreatment hemoglobin, albumin, lymphocyte, and platelet values. Receiver operating characteristic (ROC) analysis was performed to determine the optimal HALP cutoff value to predict LNM. Univariate and multivariate logistic regression analyses were conducted to identify factors associated with LNM, adjusting for established clinicopathological variables. Results: A total of 136 patients were included. Patients with LNM had significantly lower HALP scores than those without LNM (median 29.8 vs. 42.8, p = 0.001). ROC analysis demonstrated a moderate discriminative ability of HALP for predicting LNM (AUC 0.697, 95% CI 0.610–0.785), with an optimal cutoff value of 22.4. Sensitivity analysis in surgically staged patients ( n = 83) yielded consistent results (AUC 0.692; p = 0.006). In univariate analysis, HALP ≤ 22.4, tumor size > 2 cm, lymphovascular space invasion (LVSI), and parametrial involvement were significantly associated with LNM. In multivariate analysis, HALP ≤ 22.4 and LVSI remained independent predictors of LNM. Conclusion: The HALP score is a simple, inexpensive, and readily available immunonutrition index that may serve as an adjunctive biomarker for pretreatment risk stratification of LNM in patients with early and locally advanced cervical cancer. Prospective multicenter studies are warranted to confirm these findings.
- 28 April 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (5) , e70290
The Association Between the Hemoglobin–Albumin–Lymphocyte–Platelet ( HALP ) Score and Lymph Node Metastasis in Early and Locally Advanced Cervical Cancer
Objective: To investigate the association between hemoglobin–albumin–lymphocyte–platelet (HALP) score and lymph node metastasis (LNM) in patients with early and locally advanced cervical cancer. Methods: This retrospective observational cohort study included patients with FIGO 2018 stage IA–IIIC cervical cancer treated at a tertiary gynecologic oncology center between November 2022 and January 2025. Lymph node status was determined by pathological and/or radiological evaluation. HALP score was calculated using pretreatment hemoglobin, albumin, lymphocyte, and platelet values. Receiver operating characteristic (ROC) analysis was performed to determine the optimal HALP cutoff value to predict LNM. Univariate and multivariate logistic regression analyses were conducted to identify factors associated with LNM, adjusting for established clinicopathological variables. Results: A total of 136 patients were included. Patients with LNM had significantly lower HALP scores than those without LNM (median 29.8 vs. 42.8, p = 0.001). ROC analysis demonstrated a moderate discriminative ability of HALP for predicting LNM (AUC 0.697, 95% CI 0.610–0.785), with an optimal cutoff value of 22.4. Sensitivity analysis in surgically staged patients ( n = 83) yielded consistent results (AUC 0.692; p = 0.006). In univariate analysis, HALP ≤ 22.4, tumor size > 2 cm, lymphovascular space invasion (LVSI), and parametrial involvement were significantly associated with LNM. In multivariate analysis, HALP ≤ 22.4 and LVSI remained independent predictors of LNM. Conclusion: The HALP score is a simple, inexpensive, and readily available immunonutrition index that may serve as an adjunctive biomarker for pretreatment risk stratification of LNM in patients with early and locally advanced cervical cancer. Prospective multicenter studies are warranted to confirm these findings.
- Open Access
- 25 April 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Prenatal diffusion-weighted MRI in growth-restricted fetuses: early diffusion changes beyond Doppler findings: a retrospective cohort study
Although fetal growth restriction (FGR) and small for gestational age (SGA) both denote impaired fetal growth, they are distinct clinical entities defined
- 25 April 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessPrenatal diffusion-weighted MRI in growth-restricted fetuses: early diffusion changes beyond Doppler findings: a retrospective cohort study
Although fetal growth restriction (FGR) and small for gestational age (SGA) both denote impaired fetal growth, they are distinct clinical entities defined
- 8 April 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 412
Comparison of virtual reality and podcasts for improving patient experience during colposcopy: a randomized controlled trial
Purpose Colposcopy-related anxiety affects up to 80% of women, increasing pain perception and reducing satisfaction. Virtual reality has shown promise, but few studies have compared it with other active distraction methods during colposcopy. This three-arm randomized controlled trial evaluated the effectiveness of virtual reality versus podcast versus standard care in reducing anxiety and pain during colposcopy. Methods Between March and June 2025, 90 women undergoing colposcopy at a tertiary gynecologic oncology center in Turkey were randomized equally to virtual reality, podcast, or standard care. Interventions began 5 min before and continued throughout the procedure. The primary outcome was change in State-Trait Anxiety Inventory scores; secondary outcomes included Visual Analog Scale pain scores, patient satisfaction, Perceived Stress Scale scores, and 24-h analgesic use. Results Ninety participants were randomized (96.7% completion rate). In intention-to-treat analysis, both interventions reduced anxiety significantly compared with control (State-Trait Anxiety Inventory change: virtual reality –7.9, podcast –10.5, control + 6.5; p < 0.001). Virtual reality provided the strongest analgesic benefit (Visual Analog Scale 1.7 vs. 3.0 with podcast and 4.3 with control; p < 0.001) and the highest satisfaction (9.4 vs. 7.9 vs. 4.2; p < 0.001). Analgesic use was lower in the virtual reality (46.4%) and podcast (55.2%) groups compared with control (76.7%; p = 0.047). Perceived Stress Scale scores and physiological measures showed no group differences. Two participants in the virtual reality group experienced mild, self-limiting adverse effects. Conclusions Both virtual reality and podcasts significantly reduced colposcopy-related anxiety, with virtual reality providing superior pain control and satisfaction. Podcasts, as a rarely studied spoken-word distraction modality, represent a practical, low-cost alternative. These findings support integrating distraction-based strategies to improve patient experience during colposcopy.
- 8 April 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 412
Comparison of virtual reality and podcasts for improving patient experience during colposcopy: a randomized controlled trial
Purpose Colposcopy-related anxiety affects up to 80% of women, increasing pain perception and reducing satisfaction. Virtual reality has shown promise, but few studies have compared it with other active distraction methods during colposcopy. This three-arm randomized controlled trial evaluated the effectiveness of virtual reality versus podcast versus standard care in reducing anxiety and pain during colposcopy. Methods Between March and June 2025, 90 women undergoing colposcopy at a tertiary gynecologic oncology center in Turkey were randomized equally to virtual reality, podcast, or standard care. Interventions began 5 min before and continued throughout the procedure. The primary outcome was change in State-Trait Anxiety Inventory scores; secondary outcomes included Visual Analog Scale pain scores, patient satisfaction, Perceived Stress Scale scores, and 24-h analgesic use. Results Ninety participants were randomized (96.7% completion rate). In intention-to-treat analysis, both interventions reduced anxiety significantly compared with control (State-Trait Anxiety Inventory change: virtual reality –7.9, podcast –10.5, control + 6.5; p < 0.001). Virtual reality provided the strongest analgesic benefit (Visual Analog Scale 1.7 vs. 3.0 with podcast and 4.3 with control; p < 0.001) and the highest satisfaction (9.4 vs. 7.9 vs. 4.2; p < 0.001). Analgesic use was lower in the virtual reality (46.4%) and podcast (55.2%) groups compared with control (76.7%; p = 0.047). Perceived Stress Scale scores and physiological measures showed no group differences. Two participants in the virtual reality group experienced mild, self-limiting adverse effects. Conclusions Both virtual reality and podcasts significantly reduced colposcopy-related anxiety, with virtual reality providing superior pain control and satisfaction. Podcasts, as a rarely studied spoken-word distraction modality, represent a practical, low-cost alternative. These findings support integrating distraction-based strategies to improve patient experience during colposcopy.
- 27 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- No. 1
Diagnostic performance of preoperative contrast-enhanced computed tomography in predicting lymph node metastasis in endometrial cancer: a single-center study of 408 patients
Aim: To evaluate the diagnostic performance of preoperative computed tomography (CT) using a short-axis diameter threshold of ≥10 mm for predicting lymph node metastasis (LNM) in patients with endometrial cancer.Material and Methods: This retrospective single-center study included 408 patients with endometrial cancer who underwent primary surgical treatment with sentinel lymph node (SLN) mapping and/or systematic lymphadenectomy. Preoperative contrast-enhanced CT scans were reviewed, and lymph nodes with a short-axis diameter ≥10 mm were considered positive. Pathological LNM was defined as metastatic involvement in SLN and/or lymphadenectomy specimens. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and odds ratios (ORs) were calculated.Results: Pathological LNM was identified in 36 patients (8.8%). CT detected lymph node enlargement (≥10 mm) in 39 patients. The sensitivity and specificity of CT for detecting LNM were 50.0% and 94.4%, respectively. PPV was 46.2%, NPV was 95.1%, and overall diagnostic accuracy was 90.5%. CT positivity was significantly associated with pathological LNM (OR 16.7, 95% CI: 8.1–34.3, p < 0.001). However, 18 patients with LNM (50%) had no radiologically enlarged lymph nodes on CT. In multivariable analysis, CT positivity remained independently associated with LNM after adjustment for LVSI and histological type (adjusted OR: 2.83, 95% CI: 1.10–7.29, p = 0.031).Conclusion: Preoperative CT using a ≥10 mm short-axis criterion demonstrates high specificity and negative predictive value but limited sensitivity for detecting lymph node metastasis in endometrial cancer. While CT positivity markedly increases the likelihood of nodal metastasis, a negative CT does not reliably exclude microscopic disease. Therefore, surgical nodal assessment strategies should not rely solely on CT findings.
- 27 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- No. 1
Diagnostic performance of preoperative contrast-enhanced computed tomography in predicting lymph node metastasis in endometrial cancer: a single-center study of 408 patients
Aim: To evaluate the diagnostic performance of preoperative computed tomography (CT) using a short-axis diameter threshold of ≥10 mm for predicting lymph node metastasis (LNM) in patients with endometrial cancer.Material and Methods: This retrospective single-center study included 408 patients with endometrial cancer who underwent primary surgical treatment with sentinel lymph node (SLN) mapping and/or systematic lymphadenectomy. Preoperative contrast-enhanced CT scans were reviewed, and lymph nodes with a short-axis diameter ≥10 mm were considered positive. Pathological LNM was defined as metastatic involvement in SLN and/or lymphadenectomy specimens. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and odds ratios (ORs) were calculated.Results: Pathological LNM was identified in 36 patients (8.8%). CT detected lymph node enlargement (≥10 mm) in 39 patients. The sensitivity and specificity of CT for detecting LNM were 50.0% and 94.4%, respectively. PPV was 46.2%, NPV was 95.1%, and overall diagnostic accuracy was 90.5%. CT positivity was significantly associated with pathological LNM (OR 16.7, 95% CI: 8.1–34.3, p < 0.001). However, 18 patients with LNM (50%) had no radiologically enlarged lymph nodes on CT. In multivariable analysis, CT positivity remained independently associated with LNM after adjustment for LVSI and histological type (adjusted OR: 2.83, 95% CI: 1.10–7.29, p = 0.031).Conclusion: Preoperative CT using a ≥10 mm short-axis criterion demonstrates high specificity and negative predictive value but limited sensitivity for detecting lymph node metastasis in endometrial cancer. While CT positivity markedly increases the likelihood of nodal metastasis, a negative CT does not reliably exclude microscopic disease. Therefore, surgical nodal assessment strategies should not rely solely on CT findings.